HETEROARYL BENZAMIDE DERIVATIVES FOR USE AS GLK ACTIVATORS IN THE TREATMENT OF DIABETES
申请人:MCKERRECHER Darren
公开号:US20090029905A1
公开(公告)日:2009-01-29
Compounds of formula (I)
wherein R
1
, HET-1 and HET-2 are as described in the specification, and their salts and prodrugs, are activators of glucokinase (GLK) and are thereby useful in the treatment of, for example, type 2 diabetes. Processes for preparing compounds of formula (I) are also described.
式(I)中,R1、HET-1和HET-2的化合物,以及它们的盐和前药,是葡萄糖激酶(GLK)的激活剂,因此在治疗例如2型糖尿病方面非常有用。本文还描述了制备式(I)化合物的过程。